David Waterhouse

Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial

Arlene O. Siefker‐Radtke, Nobuaki Matsubara, S.H. Park et al. · Annals of Oncology · 2023 · 69 citations · Full text

Metastatic Urothelial Cancer, Urology, Genitourinary Cancer +7

A Small Tolerance for Catheter Displacement in High–Dose Rate Prostate Brachytherapy is Necessary and Feasible

Albert Tiong, Sean Bydder, Martin A. Ebert et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 61 citations

Small Tolerance, Urology, Brachytherapy +4

Highly efficient time-of-flight spectrometer for studying low-energy secondary emission from dielectrics: Secondary-electron emission from LiF film

S. Samarin, O.M. Artamonov, David Waterhouse et al. · Review of Scientific Instruments · 2003 · 33 citations

Engineering, Atomic Emission Spectroscopy, Microscopy +20

Assessment of i-125 prostate implants by tumor bioeffect

Annette Haworth, Martin A. Ebert, David Waterhouse et al. · International Journal of Radiation Oncology*Biology*Physics · 2004 · 28 citations

Urology, Genitourinary Cancer, Medicine +4

Validation of a radiobiological model for low-dose-rate prostate boost focal therapy treatment planning

Annette Haworth, Scott Williams, Hayley M. Reynolds et al. · Brachytherapy · 2013 · 27 citations

Adaptive Radiotherapy, Radiobiological Model, Medical Imaging +12